| Style | Citing Format |
|---|---|
| MLA | A Razavi ALIREZA, M Raei MAEDEH, K Shirato KEN. "Association of Ifnar2 and Tyk2 With Covid-19 Pathology: Current and Future." Frontiers in Immunology, vol. 15, no. , 2024, pp. -. |
| APA | A Razavi ALIREZA, M Raei MAEDEH, K Shirato KEN (2024). Association of Ifnar2 and Tyk2 With Covid-19 Pathology: Current and Future. Frontiers in Immunology, 15(), -. |
| Chicago | A Razavi ALIREZA, M Raei MAEDEH, K Shirato KEN. "Association of Ifnar2 and Tyk2 With Covid-19 Pathology: Current and Future." Frontiers in Immunology 15, no. (2024): -. |
| Harvard | A Razavi ALIREZA, M Raei MAEDEH, K Shirato KEN (2024) 'Association of Ifnar2 and Tyk2 With Covid-19 Pathology: Current and Future', Frontiers in Immunology, 15(), pp. -. |
| Vancouver | A Razavi ALIREZA, M Raei MAEDEH, K Shirato KEN. Association of Ifnar2 and Tyk2 With Covid-19 Pathology: Current and Future. Frontiers in Immunology. 2024;15():-. |
| BibTex | @article{ author = {A Razavi ALIREZA and M Raei MAEDEH and K Shirato KEN}, title = {Association of Ifnar2 and Tyk2 With Covid-19 Pathology: Current and Future}, journal = {Frontiers in Immunology}, volume = {15}, number = {}, pages = {-}, year = {2024} } |
| RIS | TY - JOUR AU - A Razavi ALIREZA AU - M Raei MAEDEH AU - K Shirato KEN TI - Association of Ifnar2 and Tyk2 With Covid-19 Pathology: Current and Future JO - Frontiers in Immunology VL - 15 IS - SP - EP - PY - 2024 ER - |